Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk early breast cancer Seven-year results from the ...

How Do I Take Verzenio for Early Breast Cancer? Verzenio is taken as a tablet that you will swallow. You take Verzenio twice a day, and you can take it with or without food. You should try to take ...

Verzenio monotherapy provided clinical benefits to 33% of patients with HR-positive, HER2-negative breast cancer after prior CDK4/6 inhibitor therapy. The rAMBER study highlights Verzenio's potential ...

Inluriyo, alone or with Verzenio, improved progression-free survival in ER-positive, HER2-negative advanced breast cancer compared to standard endocrine therapy. In patients with ESR1 mutations, ...

Treatment with Verzenio plus endocrine therapy demonstrated a statistically significant and clinically meaningful improvement in overall survival compared to endocrine therapy alone In the seven-year ...

How Does Verzenio Work for Metastatic Breast Cancer? Verzenio is a type of medicine called a kinase inhibitor. Kinases are enzymes in the body that can send and receive signals to help your cells do ...